Cancer Check Labs is honored to announce that Dr. Raj Attariwala, MD, PhD, FRCPC, a world-renowned expert in whole-body radiology and nuclear medicine, has joined the Cancer Check Labs Scientific & Medical Advisory Board. Dr. Attariwala is a co-author of Oncorads – a global standardized MRI technique for cancer screening, and the emeritus founder and creator of the Prenuvo scan and report. His expertise in PET/CT and whole-body MRI redefined imaging of early cancer detection and preventative healthcare.
A dual board-certified Radiologist and Nuclear Medicine physician, Dr. Attariwala trained at some of the world’s most prestigious institutions, including Memorial Sloan Kettering, UCLA and USC. He also holds a PhD in Biomedical Engineering from Northwestern University and has published extensively in peer-reviewed medical and scientific journals. His groundbreaking work in molecular imaging, artificial intelligence-driven diagnostics and precision medicine have helped thousands of patients detect cancer and other life-threatening diseases earlier than ever before. His expertise makes him an invaluable addition to Cancer Check Labs as the company continues to pioneer next– generation cancer screening solutions aimed at early detection and longevity focused healthcare.
“As a diagnostician and engineer, I recognize that in medicine, there is no such thing as a perfect test, and everyone knows that when it comes to cancer, early detection results in better outcomes. Whole body MRI in its current form is challenging to scale, and what excites me about Cancer Check Labs’ approach is that it embraces widely accepted pathologic analytical techniques and provides an early window into cancer detection by identifying whole, intact circulating tumor cells at their earliest of stages versus any other blood test on the market. Tests in cancer screening that aid in certainty of diagnosis for early detection has the potential to save countless lives by giving people more time and more options for treatment.” said Dr. Attariwala.
Dr. Attariwala’s appointment underscores Cancer Check Labs’ commitment to innovation in minimally invasive, highly accurate cancer screening. Throughout his career, he has pushed the boundaries of diagnostics, emphasizing the importance of early detection before symptoms arise, when conditions are most treatable. His work has been widely recognized in the medical community for its role in enhancing preventative healthcare and improving patient outcomes.
Beyond his technological innovations, Dr. Attariwala is a sought-after educator, speaker, and thought leader in diagnostic imaging, longevity science, and precision health. His insights into whole-body imaging and early cancer detection have influenced how clinicians and researchers approach proactive medicine. His addition to Cancer Check Labs’ Scientific & Medical Advisory Board will provide strategic guidance as the company continues to refine and expand its cutting-edge solutions.
“We are honored to welcome Dr. Attariwala to our advisory board,” said Sumit Rai, Founder, Chairman, and CEO of Cancer Check Labs. “His groundbreaking work in radiology and unwavering commitment to early detection aligns perfectly with our mission of providing the most advanced and accurate cancer screening available today. With his expertise, we will continue to push the boundaries of innovation in cancer diagnostics and longevity-focused healthcare.”
Cancer Check Labs is redefining cancer detection by utilizing state-of-the-art technology that goes beyond traditional screening methods. Unlike other tests that rely solely on genetic markers or fragments of DNA, Cancer Check physically isolates whole, intact circulating tumor cells (CTCs) from a simple blood sample. Because CTCs have been detected as early as Stage 0, Cancer Check arguably provides the earliest cancer detection test available today, allowing individuals and healthcare providers to act sooner and improve survival outcomes.
The addition of Dr. Attariwala to the advisory board further strengthens the company’s mission to expand access to life-saving early detection technologies and set new standards in preventative healthcare.
About Cancer Check Labs
Cancer Check Labs is on a mission to save lives through early detection. Cancer Check is a test that can screen for 200+ cancers by physically extracting whole, intact circulating tumor cells (CTCs) from a blood sample. Because CTCs have been detected in blood samples as early as Stage 0, Cancer Check arguably provides the earliest cancer detection test available today. Cancer Check Labs is headquartered in Medical District in Dallas, TX.
About Cancer Check
The Cancer Check test is not intended to replace other established evidence-based screening, diagnostic, and medical guidelines and practices for the detection of cancer. Similar to other medical tests, the Cancer Check test is not perfect and has limitations to detect all cancers.
